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OBJECTIVES The study was done to define the incidence, determinants and prognostic implications of
onset of atrial fibrillation (AF) during follow-up of mitral regurgitation (MR) initially in sinus
rhythm.
BACKGROUND The rates and clinical implications of AF in MR are undefined.
METHODS We analyzed the occurrence of AF under conservative management in two populations of
patients with degenerative MR in sinus rhythm at diagnosis: 1) 360 patients (65  13 years,
74% men) with MR due to flail leaflets; and 2) 89 residents of Olmsted County, Minnesota
(67  17 years, 56% men) with grade 3 or 4 MR due to simple mitral valve prolapse (MVP)
diagnosed echocardiographically.
RESULTS In patients with MR due to flail leaflets, AF rates at 5 and 10 years were 18  3% and 48 
6%, respectively, and the linearized rate was 5.0  0.7% per year. Development of AF during
follow-up was independently associated with high risk of cardiac death or heart failure
(adjusted risk ratio 2.23, p 0.025). The AF rate at 10 years was higher in patients65 years
(75  10% vs. 24  6%, p  0.0001) and in those with baseline left atrial (LA) dimension
50 mm (67  8% vs. 37  9%, p  0.001). In multivariate analysis, independent baseline
predictors of AF were age and LA diameter (both p  0.01). In patients with MR due to
MVP, similar rates of AF (41  7% vs. 44  6% at nine years, p  0.50) and predictors of
AF (age and LA dimension, both p  0.006) were noted.
CONCLUSIONS In patients with degenerative MR in sinus rhythm at diagnosis, the incidence of AF occurring
under conservative management is high and similar whether the cause of MR is flail leaflet
or simple MVP. After onset of AF, an increased cardiac mortality and morbidity are both
observed under conservative management. The risk of AF increases with advancing age and
larger LA dimension. These data suggest that the clinical management of MR should take
into account the high incidence, excess risk, and predictors of AF. (J Am Coll Cardiol 2002;
40:84–92) © 2002 by the American College of Cardiology Foundation
Atrial fibrillation (AF) is the most common arrhythmia (1)
and is associated with an adverse prognosis (2,3). Therefore,
identifying predisposing factors for AF (4–6), with the aim
of improving strategies for its primary prevention, is essential.
Valvular heart diseases are associated with AF in the
population (3–5), with a high population-attributable risk
(6), but the specific risk of AF attached to each valvular
lesion has not been well delineated (7). Furthermore,
long-term risks and baseline predictors of AF in patients
who were in sinus rhythm at diagnosis are poorly defined.
Mitral regurgitation (MR) is of particular interest regard-
ing the development of AF because MR is common (8),
particularly in the elderly (8), who are also at high risk for
AF (6), and because MR tends to produce left atrial (LA)
enlargement, a possible precursor of AF (9). In previous
studies of patients with MR, those with preoperative AF
had a worse postoperative outcome than those in sinus
rhythm (10). However, in patients conservatively managed,
series of limited size reported a highly variable incidence of
AF (7,11,12). Furthermore, the predictors of onset of AF in
patients diagnosed with MR in sinus rhythm and the
implications of AF for outcome under conservative (medi-
cal) management remain uncertain. Therefore, because of
these conflicting or insufficient data regarding AF compli-
cating MR, the concept of AF prevention, which may be of
great importance, lacks substantiation and has not been
implemented in the current guidelines regarding surgical
decision making (13).
Patients with degenerative MR either with flail leaflets
(14) or with simple mitral valve prolapse (MVP) represent
the largest subset of candidates for MR surgery in Western
countries (15), and they are an important population in
which to determine the incidence and impact on outcome of
AF. Also, flail leaflets (16,17) and more recently MVP (18)
are reliably diagnosed by echocardiography, allowing long-
term follow-up of large populations. Accordingly, in pa-
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tients who were in sinus rhythm when degenerative MR was
diagnosed, we examined the long-term incidence, predis-
posing factors and prognostic implications of the develop-
ment of AF.
SUBJECTS AND METHODS
The design of the study was a retrospective collection of
cases in which the diagnosis, clinical and echocardiographic
characteristics and subsequent events were independently
noted (prospectively) during normal clinical care.
Patient population. Two populations of patients with
degenerative MR in sinus rhythm at diagnosis were eligible
for the study. The first population included patients with
MR due to flail leaflets first diagnosed by two-dimensional
echocardiography between January 1, 1980, and December
31, 1994, at the Mayo Clinic (Rochester, Minnesota). To
determine whether AF rates and implications are similar in
other patients with degenerative MR, we analyzed a second
population involving patients who: 1) had MR due to MVP
diagnosed between 1989 and 1995; 2) were Olmsted
County, Minnesota, residents at diagnosis; and 3) had MR
grade 3 or 4/4 by standard Doppler methods (all had
comprehensive Doppler and color-flow imaging). In both
populations, patients who had papillary muscle rupture,
ischemic MR with isolated annular dilation, previous valve
surgery or associated aortic or congenital disease were
excluded. Patients who subsequently were identified with
associated coronary disease or underwent bypass grafting at
valvular surgery were not excluded.
Clinical data were obtained from medical records, and
follow-up was obtained through clinical records, postal
survey and telephone calls to patients, relatives or physi-
cians. Confirmation of AF was based on electrocardiograms
(12), and no unsubstantiated episode of palpitation was
considered AF. Causes of death were ascertained by con-
tacting patients’ physicians and by examining death certifi-
cates and autopsy records. Associated medical conditions
were assigned weights and summated as a modified comor-
bidity index (19).
Echocardiographic methods. Comprehensive two-
dimensional echocardiography was performed (20). The
diagnosis of flail leaflets was based on failure of leaflet
coaptation, with rapid systolic movement of the flail seg-
ment into the LA (16,21). The diagnosis of MVP was based
on current criteria, using long-axis views of the valve (18).
Severity of MR was assessed semiquantitatively on a scale of
1 to 4 by Doppler echocardiography (22,23). Left
ventricular (LV) and LA dimensions were obtained by using
M-mode echocardiography, guided by two-dimensional
imaging. Ejection fraction (EF) was visually estimated in all
cases and was combined with calculated values as previously
reported (12,24,25). Data were used unaltered from the
original prospective echocardiographic data collection by
means of electronic transfer.
Statistical analysis. Continuous variables are expressed as
mean  SD and categorical data as percentages. Group
comparisons were performed with analysis of variance,
standard t test, or chi-square test as appropriate. After
diagnosis, event rates were estimated by the Kaplan-Meier
method, expressed as mean  SE, and linearized rates were
calculated as gross estimates of the hazard of AF. The main
end point was occurrence of AF under conservative man-
agement, which was analyzed by censoring at the time of
mitral valve surgery if eventually performed. Therefore, in
all patients the time after diagnosis during which patients
remained medically treated or managed was the time at risk
for AF whether they had subsequent surgery or not.
Identification of baseline predictors of AF was based on
univariate Cox proportional hazards analysis of candidate
clinical, laboratory and echocardiographic variables, with
associated risk expressed as risk ratio (RR) and 95% confi-
dence interval (CI). To account for effect of gender, body
size, height, weight, body mass index (BMI), body surface
area (BSA) and LV and LA sizes were used as absolute
values or were normalized to the mean of each gender
group. Age, gender and variables with univariate p  0.10
were then tested in a multivariate model. To determine the
impact of follow-up AF on subsequent outcome (death or
heart failure) under conservative (medical) management, a
time-dependent AF variable was tested within multivariate
models (including baseline predictors) for the specific event,
censoring patients at surgery (if operated on). Comparison
of event rates between groups employed the two-tailed
log-rank test, and between observed and expected survival
the one-tailed log-rank test was used. A p value of 0.05
was considered statistically significant.
RESULTS
Baseline characteristics. MR DUE TO FLAIL LEAFLETS.
From a cohort of 468 patients with the diagnosis made by
echocardiography from 1980 through 1994, a total of 360
(aged 65  13 years, 74% men) met eligibility criteria. At
presentation, 209 of these patients (58%) were in New York
Heart Association (NYHA) functional class I, 82 (23%) in
class II, 52 (14%) in class III and 17 (5%) in class IV.
Subsequently, 234 patients (65%) underwent surgery 2.1 
Abbreviations and Acronyms
AF  atrial fibrillation
BMI  body mass index
BSA  body surface area
CHF  congestive heart failure
CI  confidence interval
EF  ejection fraction
LA  left atrium/atrial
LV  left ventricle/ventricular
MR  mitral regurgitation
MVP  mitral valve prolapse
NYHA  New York Heart Association
RR  risk ratio
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2.9 years after diagnosis. Of the patients initially in NYHA
functional class III or IV, 55 underwent surgery; 14 were not
operated on because all had improved clinically after receiv-
ing medical treatment (n  14) and also were not surgical
candidates (n  4) or refused surgery (n  2). The
presumed cause of flail leaflet was idiopathic in 295 patients,
infective endocarditis in 58 patients, trauma in 5 patients
and miscellaneous causes in 2 patients. The LV systolic and
diastolic diameters, EF and wall thickness were 35  6 and
60 7 mm, 64 9% and 11 1 mm, respectively. The LA
diameter was 50 8 mm. Among the 330 patients in whom
MR was graded by Doppler echocardiography, 277 (84%)
had grade 3 or 4/4 regurgitation. Follow-up was
complete for 357 patients (99%).
MR DUE TO MVP. Among 645 residents of Olmsted County,
Minnesota, diagnosed with MVP between 1989 and 1995,
89 had severe MR (grade 3 or 4) and were in sinus rhythm
at diagnosis. Compared with patients with flail leaflets,
those with MVP had similar age (67 17 vs. 65 13 years,
p  0.22), comorbidity (p  0.38), NYHA functional class
(III to IV in 19 vs. 19%, p  0.90) and BMI (24.2  4 vs.
24.5  4, p  0.50). However, patients with MVP had
slightly lower EF (61  11 vs. 64  9%, p  0.03), had
smaller LA (46  10 vs. 50  8 mm, p  0.002) and were
more often women (44 vs. 26%, p  0.02). During
follow-up, 35 patients (39%) underwent surgery 3.7  2.8
years after diagnosis.
Incidence of AF. MR DUE TO FLAIL LEAFLETS. During
follow-up under medical management (38  40 months),
56 patients experienced AF and 304 remained in sinus
rhythm. At 5 and 10 years, overall rates of AF were 18 3%
and 48  6%, respectively (Fig. 1). Yearly linearized rate of
AF was 5.0  0.7%. The mean time to occurrence of AF
was 52  32 months. The initial episode of AF was
paroxysmal in 25 patients, representing a 10-year rate of
24 5%, but subsequent recurrence was 49 12% at 1 year
and 56  12% at 2 years. The first episode of AF was
permanent in 31 patients. Accounting for recurrence of AF,
the 10-year rate of permanent AF was 32  6%. After
surgery in the 234 patients, the total rate of AF was 6% at
3 months and 37  5% at 10 years.
MR DUE TO MVP. Under medical management, 19 patients
incurred AF, with an incidence rate similar to that of
patients with flail leaflets (at 9 years 41  9% vs. 44  6%,
p  0.67). When all 449 degenerative MR patients were
combined, the 5-year and 10-year rates of AF were 18 3%
and 47  5%, respectively. Of note, survival under conser-
vative management was similar whether MR was due to
MVP or flail leaflets (9-year, 61 8 vs. 60 5%; p 0.70),
with 5-year and 10-year survival under conservative man-
agement for all degenerative MR of 78  3% and 52  5%,
respectively.
Determinants of AF. MR DUE TO FLAIL LEAFLETS. For
descriptive purposes, baseline characteristics of the patients
who had AF under conservative management compared
with those who remained in sinus rhythm under conserva-
tive management and with those who remained in sinus
rhythm until they underwent mitral surgery are presented in
Table 1 (left panel). Although these groups were different
globally, few variables were different between the group with
AF and that with persistent sinus rhythm under conserva-
tive medical management (as opposed to the surgical
group). In particular, age and LA size were different. Of
note, a history of myocardial infarction was not observed
Figure 1. Incidence of atrial fibrillation (AFib) under conservative (medical) management among patients with mitral regurgitation due to flail leaflets
diagnosed with the patient in sinus rhythm. The overall rates of new atrial fibrillation and of permanent and paroxysmal atrial fibrillation are presented as
Kaplan-Meier curves.
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with higher prevalence at diagnosis in patients who devel-
oped AF during conservative follow-up (Table 1). This
result is consistent with the prevalence of coronary disease in
the 191 patients who underwent coronary angiography at
any point during follow-up (10/33 or 30% in patients with
AF, 2/4 in patients without AF and followed conservatively
and 45/154 or 30% in patients who remained in sinus
rhythm until surgery [p  0.69]). However, compared with
all patients who remained in sinus rhythm, those who had
AF remained under conservative management (instead of
undergoing surgery) more often (at five years, 64  6 vs.
37  3%; p  0.001) and for a longer time (2,162  1,283
days from diagnosis vs. 1,062  1,239 days, p  0.0001).
Therefore, it is essential to analyze the end point of time
to occurrence of AF under conservative management with
the Cox proportional hazards method (Table 1, right panel).
The baseline clinical predictors of time to AF were age (p
0.0001) and comorbidity (p  0.045), with borderline effect
of female gender (p  0.14). Incidence of AF was higher in
patients65 years versus65 years (75 10% vs. 24 6%
at 10 years, p  0.0001, Fig. 2). Yearly rates of AF in
patients 65 years and 65 years were 6.9  1.1% and
2.8  0.7%, respectively (p  0.0001).
The LA dimension was the only echocardiographic
variable (p  0.0004) predictive of time to AF. Of note,
severe MR was neither more prevalent nor associated with
shorter time to AF (Table 1). Incidence of AF was higher
with LA dimension 50 mm versus 50 mm (at 10 years,
67  8% vs. 37  9%; p  0.0001; Fig. 3). Yearly rates of
AF with LA 50 mm and 50 mm were 8.4  1.6% and
2.9 0.7%, respectively (p 0.0001). The predictive power
of uncorrected LA dimension was not improved by normal-
izing LA diameter by gender and was superior to that of the
LA diameter normalized to BSA, which was only marginal
(p  0.08). The LV EF or diameters (normalized or not to
BSA) showed no association with AF. Also, patients with
and without MR grade 3 or 4 had similar rates of AF (at 10
years, 44  7% vs. 49  14%, respectively; p  0.40).
MR DUE TO MVP. The only baseline predictors of AF were
age and LA diameter, with RRs (age: RR [95% CI] 
1.05/year [1.03 to 1.07], p  0.0001; LA diameter:
1.07/mm [1.04 to 1.10], p 0.0001) very similar (p 0.12)
to those of patients with flail leaflet (Table 1, right panel).
MULTIVARIATE ANALYSIS. In MR due to flail leaflets, using
original baseline variables, age and LA dimension were the
only independent predictors of AF, and female gender
showed a borderline trend (Table 2A). Similarly, in the
entire population of degenerative MR (combining flail
leaflets and MVP), age 65 years and LA 50 mm were
predictors of AF (Table 2B) independently of gender.
However, LA size was smaller in women than in men (47
8 vs. 50  9 mm, p  0.007 overall), which may potentially
bias the effect of LA size and gender on incidence of AF.
Therefore, first, multivariate models were repeated sepa-
rately in men and women. In both genders, adjusting for
Table 1. Baseline Characteristics of Patients With MR Due to Flail Leaflets and Association With Subsequent Development of AF
Baseline Characteristics According to Outcome
Association With Time

















Age (yrs) 70  9 70  12 61  13* 0.0001 1.046 1.022–1.072 0.0001
Male gender 66% 74% 76% 0.37 0.67 0.39–1.19 0.14
NYHA functional class III to IV 5% 13% 26%* 0.0001 2.06 0.48–6.04 0.29
Hypertension 27% 31% 30% 0.84 0.96 0.54–1.79 0.89
Comorbidity index 2 66% 66% 81%* 0.008 0.52 0.30–0.94 0.045
BSA (m2) 1.85  0.22 1.80  0.23 1.88  0.20 0.01 1.05 0.34–3.49 0.93
BSA normalized by gender 1.02  0.10 0.97  0.10* 1.01  0.08 0.001 8.86 0.49–2.18 0.15
BMI (kg/m2) 25.1  4.6 24.0  4.1 24.6  3.4 0.15 1.03 0.96–1.09 0.36
Smoking 34% 47% 41% 0.29 1.20 0.70–2.13 0.51
Serum creatinine (mg/dl) 1.3  1.1 1.4  1.1 1.1  0.3* 0.04 1.26 0.87–1.57 0.18
Total cholesterol (mg/dl) 214  77 207  96 210  46 0.88 1.00 0.99–1.003 0.70
History of MI 5% 13% 4% 0.02 1.06 0.39–4.36 0.92
Ejection fraction (%) 64  9 63  10 64  8 0.36 0.994 0.96–1.03 0.75
LVS (mm) 34  6 34  7 36  6 0.02 0.99 0.94–1.04 0.70
LVD (mm) 60  8 56  6* 62  7 0.01 1.008 0.96–1.047 0.70
LA (mm) 50  8 46  7* 51  8 0.0001 1.064 1.027–1.10 0.0006
WT (mm) 11  1 11  1 11  1 0.20 1.12 0.89–1.39 0.34
Severe MR 78% 70% 93%* 0.0001 1.33 0.70–2.74 0.39
*Denotes p  0.05 in comparison with patients in whom AF developed under conservative management. †Time to AF is for events occurring under conservative management.
Continuous variables are expressed as mean  SD and categorical variables as percentages.
AF atrial fibrillation; BMI body mass index; BSA body surface area; CI confidence interval; LA left atrial diameter; LVD end-diastolic left ventricular diameter;
LVS  end-systolic left ventricular diameter; MI  myocardial infarction; MR  mitral regurgitation; NYHA  New York Heart Association; SR  sinus rhythm; WT 
end-diastolic wall thickness.
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age, the absolute LA size (adjusted RR  3.17 and 1.73 per
10-mm increment, p  0.0001 and p  0.007 in women
and in men, respectively) was independently predictive of
AF.
Second, multivariate analysis was repeated in the entire
population using LA diameter normalized to gender, show-
ing that age and LA remained independently predictive of
AF incidence (Table 2C) and that gender was not associated
with AF after diagnosis. Symptoms, comorbidity, history of
myocardial infarction, all risk factors for coronary disease
and cause of degenerative MR (MVP vs. flail leaflets) were
not independently predictive of AF (all p  0.40).
Impact of onset of AF on mortality and morbidity. In
MR due to flail leaflets, during conservative follow-up 67
deaths (44 [66%] cardiovascular) occurred. At 10 years, the
observed survival rate was lower than the expected survival
of the general population of same age and gender (53  5%
vs. 64%, p  0.051). Using time-dependent analysis, onset
of AF during follow-up was associated with an increased
risk of subsequent death (RR  3.42, 95% CI  1.7 to 6.7,
p  0.0001). Multivariate analysis confirmed that new AF
during follow-up was independently (of age, NYHA func-
tional class at baseline and EF) associated with increased
mortality (adjusted RR  2.02, p  0.056) (Fig. 4).
Similarly, 78 patients with flail leaflets experienced con-
gestive heart failure (CHF) under conservative manage-
ment. Onset of new AF during follow-up was associated
with a higher risk of CHF (RR  3.23, 95% CI  1.59 to
Figure 2. Atrial fibrillation (AFib) rate in patients with mitral regurgitation due to flail leaflets diagnosed with the patient in sinus rhythm, according to
age at diagnosis, 65 or 65 years old (yo). Note the considerably higher rate in older patients.
Figure 3. Atrial fibrillation (AFib) rate in patients with mitral regurgitation due to flail leaflets diagnosed with the patient in sinus rhythm, according to
left atrial diameter at diagnosis 50 or 50 mm. Note the considerably higher rate in patients with a markedly dilated left atrium.
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6.58, p  0.001). In multivariate analysis, new AF was
independently (adjusting for baseline age, NYHA func-
tional class and EF) associated with CHF (adjusted RR 
2.26, p  0.032) whether AF was initially permanent or
paroxysmal (p  0.09). Rates of cardiac death and CHF at
5 and 10 years were 31 3% and 59 5%, respectively, and
were independently higher after new AF (adjusted RR 
3.13, p  0.0009). When examined in all patients with
degenerative MR, AF during follow-up remained associated
with higher rate of subsequent CHF (adjusted RR [95% CI]
4.85 [2.89 to 8.14], p  0.0001) and of CHF or cardiac
death (adjusted RR [95% CI]  4.37 [2.74 to 6.97], p 
0.001).
DISCUSSION
The present study shows that AF is a common complication
in patients with degenerative MR while they are conserva-
tively managed, occurring at a linearized rate of 5% per year.
The incidence of AF is similar whether MR is due to flail
leaflets or MVP. The onset of AF is independently associ-
ated with an increased risk of adverse cardiac death and
heart failure. With advancing age, the risk of AF increases
markedly. The LA dimension in sinus rhythm is also a
major independent predictor of subsequent AF under con-
servative management. The high frequency and severe
consequences of the development of AF and its association
with LA size suggest that consideration should be given to
preventing LA enlargement and to incorporating LA size in
the clinical decision-making process in patients with MR.
AF in patients with MR. Atrial fibrillation is a common
arrhythmia associated with an adverse prognosis (2,3). In
the population, valvular disease is a risk factor for AF (4,6),
but the incidence and implications of AF in specific valvular
diseases remain uncertain. Such data are particularly impor-
tant in MR because of the current high prevalence of MR
(8) and of the uncertainties regarding the implications of
AF in its management (13).
Although mild functional MR is common in primary AF
(26), in MR due to organic valve diseases AF has been
variably reported as rare (7,11) or relatively frequent (12) in
small series that did not permit definition of determinants
and outcome implications of AF. In the present study of
patients with isolated pure degenerative MR due to MVP or
flail leaflets, and who were conservatively managed after
diagnosis in sinus rhythm, AF occurred frequently—in
almost half the patients at 10 years, corresponding to a
linearized rate of 5% per year. This rate includes permanent
Table 2. Multivariate Predictors of Atrial Fibrillation
Variable Unit Risk Ratio 95% CI p Value
A. Models Using Original Variables in Patients With MR Due to
Flail Leaflets
Age Per year 1.044 1.02–1.08 0.002
Gender Per female 1.85 0.98–3.40 0.057
LA Per mm 1.08 1.04–1.12 0.0002
B. Models Using Original Variables in All Patients With
Degenerative MR
Age  65 years 2.76 1.64–4.86 0.0001
Gender Per female 1.47 0.89–2.37 0.14
LA  50 mm 2.77 1.72–4.45 0.0001
C. Models Using Normalized Variables in All Patients With
Degenerative MR
Age  65 years 3.26 1.79–6.36 0.0001
Gender Per female 1.30 0.75–2.20 0.34
LA-normalized Per 10% increase 1.46 1.25–1.68 0.0001
CI  confidence interval; LA  left atrial diameter; LA-normalized  LA/(mean
LA of patient gender) (10% increase in LA-normalized is 5.0 mm in men and 4.7 mm
in women); MR  mitral regurgitation.
Figure 4. Survival of patients with mitral regurgitation due to flail leaflets adjusted for age, gender, ejection fraction and symptoms at baseline, and
separating at the fourth year after diagnosis those patients with and those without postdiagnosis atrial fibrillation. Note the excess mortality in patients with
follow-up atrial fibrillation. SR  sinus rhythm; AF  atrial fibrillation; F-U  follow-up.
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and paroxysmal AF, but combining these two forms is
justified by previous reports and by our present data,
suggesting that the prognosis of these two forms of AF may
not be distinguishable (27).
Moreover, the high recurrence of AF after a first episode
suggests that distinguishing paroxysmal from permanent
AF is moot and that any AF should be considered a
harbinger of clinical complications. Indeed, in the present
series, we noted—to our knowledge for the first time—that
the occurrence of AF in patients with MR is independently
associated with an increased risk of death and heart failure
under conservative management. After occurrence of AF,
the risk of death or CHF more than doubles, even adjusting
for baseline predictors of outcome. The grave prognosis of
AF justifies defining the determinants of AF during follow-
up.
Factors predisposing to AF in patients with MR. In the
population, advancing age is linked with higher rates of AF
(4,6,28). A link between AF and coronary disease has been
suggested (29) but most often denied (30,31), and this was
not observed in our series. The mechanism by which aging
influences the occurrence of AF remains unclear, but it may
be related to structural or functional properties of atrial
tissue (32). Nevertheless, AF is also frequent in younger
patients with MR initially in sinus rhythm, occurring in
almost one-fourth of them at 10 years and suggesting that
other predisposing factors may lead to AF.
We observed a trend for slightly higher risk of AF in
women. This trend, noted previously (6,33) although not
consistently (34), was insignificant, particularly when gen-
der differences in LA size were accounted for. Also, iden-
tical rates of AF were noted in MR due to flail leaflets and
MVP, showing that AF is a complication of MR and not of
a specific mitral lesion. Nevertheless, the lack of significant
association between degree of MR and AF rate in patients
with flail leaflet probably reflects a rapid progression of MR
and of LA enlargement in these patients (35).
Thus, an important observation of this study is that LA
enlargement is not a benign compensatory phenomenon in
MR but leads to AF and its complications. A large atrial size
has long been noted with chronic AF (36). However, this
study demonstrates that in patients with degenerative MR
in sinus rhythm at diagnosis, LA enlargement precedes and
predisposes to the development of AF (4,5,9). Because AF
seems to result from micro–re-entrant circuits (37), LA
anatomic and electrical properties contribute to the arrhyth-
mia (9). Left atrial enlargement preceding AF may be
related to larger regurgitant volume (38) or to alterations of
atrial myocardium (39), or to both, but in any case, LA
dilation disturbs impulse propagation, leading to AF (5).
Indeed, LA dimension remains independently predictive of
AF, even after controlling for other markers of volume
overload, such as LV size and function. Therefore, the
clinical implications of these data should be considered.
Clinical implications. Occurrence of AF was indepen-
dently related to excess mortality and morbidity under
conservative management, in contrast to the fact that AF in
asymptomatic patients with MR is labeled a class II indi-
cation for surgery (13). In view of the present results and the
high maintenance of sinus rhythm if surgery is performed
promptly after the onset of AF (40), it appears reasonable
that recent onset of AF be considered a class I indication for
surgery. Indications for the MAZE procedure (41) in MR
with AF are not fully defined, but the relatively low
additional risk of the atrial procedure suggests that such a
combination can be considered (42).
Prevention of AF in MR is important. Prevention of LA
enlargement has not yet been demonstrated. Early surgery
appears to prevent cardiovascular morbidity (43) and may
minimize complications related to marked LA enlargement
(44), but its role in preventing AF is uncertain. The role of
vasoactive treatment in MR has not been defined (13,45),
but it may reduce LA size (46). In view of our data, clinical
trials testing possible prevention of LA enlargement and AF
in MR are needed.
Study limitations. Only AF demonstrated by electrocar-
diogram was considered. Thus, brief or unrecorded AF
episodes may have been ignored. This approach, justified by
potential misclassifications (6), was used in population
studies of AF (5,6,9).
The echocardiographic diagnosis of flail leaflet (16,17)
and MVP (18) at different dates has become reliable and
widely accepted and, therefore, the two populations are not
totally simultaneous and their results are presented sepa-
rately. Remarkably, the rates, predictors and impact of AF
are identical, showing the robustness of the present data,
which can be applied to all degenerative MR. For clinical
outcome, a referral bias is often possible. However, in both
uni- and multivariate analyses, AF rates were similar (p 
0.67 and p  0.47) in community-based MVP and flail
leaflet patients, and adjustment for comorbidity did not
affect the results (p  0.40), suggesting a low probability of
referral bias.
The link between LA enlargement and subsequent AF
may be questioned. However, LA size is also a marker of
subsequent AF in the general population (5,6,9), of subse-
quent heart failure in MR (12), and even of subsequent
mortality after surgery (47). Importantly, LA size normal-
ized to BSA was a less powerful predictor of AF than was
the absolute LA diameter or LA simply normalized to the
mean by gender.
Conclusions. Patients with degenerative MR diagnosed in
sinus rhythm, while under conservative management, incur
subsequent AF frequently, in close to half of them at 10
years. The occurrence of AF is independently associated
with a higher rate of subsequent adverse cardiac events.
These findings suggest that prompt surgical consideration
should be given to patients with severe MR in whom AF
develops. Advancing age and LA enlargement at baseline
are major predisposing factors for the development of AF.
Therefore, the degree of LA enlargement, as a predictor of
subsequent AF, should be taken into account when surgery
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is considered in patients with degenerative MR in sinus
rhythm, and the possibility of preventing progression of LA
enlargement should be evaluated in controlled trials in
patients with MR.
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